Is this just first mover advantage (and if so it changes some of my thoughts about investments and also about prescription decisions are made)? Or is there some other factor I've missed?
I'd add JNJ and Bayer agressive marketing power, more indications and QD dosing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.